| MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia Y Pikman, BH Lee, T Mercher, E McDowell, BL Ebert, M Gozo, A Cuker, ... PLoS medicine 3 (7), e270, 2006 | 1779 | 2006 |
| American Society of Hematology 2019 guidelines for immune thrombocytopenia C Neunert, DR Terrell, DM Arnold, G Buchanan, DB Cines, N Cooper, ... Blood advances 3 (23), 3829-3866, 2019 | 1021 | 2019 |
| American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism TL Ortel, I Neumann, W Ageno, R Beyth, NP Clark, A Cuker, BA Hutten, ... Blood advances 4 (19), 4693-4738, 2020 | 876 | 2020 |
| Hemophilia B gene therapy with a high-specific-activity factor IX variant LA George, SK Sullivan, A Giermasz, JEJ Rasko, BJ Samelson-Jones, ... New England Journal of Medicine 377 (23), 2215-2227, 2017 | 727 | 2017 |
| 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert … GF Tomaselli, KW Mahaffey, A Cuker, PP Dobesh, JU Doherty, ... Journal of the American College of Cardiology 70 (24), 3042-3067, 2017 | 628 | 2017 |
| American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia A Cuker, GM Arepally, BH Chong, DB Cines, A Greinacher, Y Gruel, ... Blood advances 2 (22), 3360-3392, 2018 | 605 | 2018 |
| Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum GD Barnes, A Burnett, A Allen, M Blumenstein, NP Clark, A Cuker, ... Journal of thrombosis and thrombolysis 50, 72-81, 2020 | 583 | 2020 |
| Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis A Cuker, PA Gimotty, MA Crowther, TE Warkentin Blood, The Journal of the American Society of Hematology 120 (20), 4160-4167, 2012 | 513 | 2012 |
| Laboratory measurement of the anticoagulant activity of the non–vitamin K oral anticoagulants A Cuker, DM Siegal, MA Crowther, DA Garcia Journal of the American College of Cardiology 64 (11), 1128-1139, 2014 | 506 | 2014 |
| American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 A Cuker, EK Tseng, R Nieuwlaat, P Angchaisuksiri, C Blair, K Dane, ... Blood advances 5 (3), 872-888, 2021 | 444 | 2021 |
| Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines Z Zhai, C Li, Y Chen, G Gerotziafas, Z Zhang, J Wan, P Liu, I Elalamy, ... Thrombosis and haemostasis 120 (06), 937-948, 2020 | 429 | 2020 |
| Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review BT Samuelson, A Cuker, DM Siegal, M Crowther, DA Garcia Chest 151 (1), 127-138, 2017 | 327 | 2017 |
| The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion A Cuker, G Arepally, MA Crowther, L Rice, F Datko, K Hook, KJ Propert, ... Journal of thrombosis and haemostasis 8 (12), 2642-2650, 2010 | 291 | 2010 |
| Reversal of direct oral anticoagulants: guidance from the anticoagulation forum A Cuker, A Burnett, D Triller, M Crowther, J Ansell, EM Van Cott, D Wirth, ... American journal of hematology 94 (6), 697-709, 2019 | 285 | 2019 |
| Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism MA Smythe, J Priziola, PP Dobesh, D Wirth, A Cuker, AK Wittkowsky Journal of thrombosis and thrombolysis 41, 165-186, 2016 | 255 | 2016 |
| The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli IN Chernysh, C Nagaswami, S Kosolapova, AD Peshkova, A Cuker, ... Scientific reports 10 (1), 5112, 2020 | 209 | 2020 |
| How I treat heparin-induced thrombocytopenia A Cuker, DB Cines Blood, The Journal of the American Society of Hematology 119 (10), 2209-2218, 2012 | 199 | 2012 |
| 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous … DJ Kumbhani, CP Cannon, CJ Beavers, DL Bhatt, A Cuker, TJ Gluckman, ... Journal of the American College of Cardiology 77 (5), 629-658, 2021 | 189 | 2021 |
| Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A A Tiede, B Brand, R Fischer, K Kavakli, SR Lentz, T Matsushita, C Rea, ... Journal of Thrombosis and Haemostasis 11 (4), 670-678, 2013 | 189 | 2013 |
| Pathogenesis of immune thrombocytopenia DB Cines, A Cuker, JW Semple La Presse Médicale 43 (4), e49-e59, 2014 | 168 | 2014 |
Mark CrowtherMcMaster University在 mcmaster.ca 的电子邮件经过验证
